A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects. [electronic resource]
Producer: 20190415Description: 1724-1730 p. digitalISSN:- 1520-6017
- Adult
- Aminoisobutyric Acids
- Antiviral Agents -- administration & dosage
- Area Under Curve
- Benzimidazoles -- administration & dosage
- Biological Availability
- Cross-Over Studies
- Cyclopropanes
- Female
- Humans
- Lactams, Macrocyclic
- Leucine -- analogs & derivatives
- Male
- Middle Aged
- Particle Size
- Proline -- analogs & derivatives
- Pyrrolidines
- Quinoxalines -- administration & dosage
- Sulfonamides -- administration & dosage
- Tablets
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.